Treatment of heparin induced thrombocytopenia and thrombosis during the first trimester of pregnancy.
Mehta
R
R
Golichowski
A
A
D000328:Adult; D000925:Anticoagulants / Q000627:therapeutic use; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006493:Heparin / Q000009:adverse effects; D006629:Hirudins / Q000031:analogs & derivatives*; D006801:Humans; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000139:chemically induced / Q000188:drug therapy*; D011250:Pregnancy Complications, Hematologic / Q000139:chemically induced / Q000188:drug therapy*; D011261:Pregnancy Trimester, First; D011994:Recombinant Proteins / Q000627:therapeutic use*; D013921:Thrombocytopenia / Q000139:chemically induced / Q000150:complications* / Q000188:drug therapy*; D013927:Thrombosis / Q000139:chemically induced / Q000150:complications* / Q000188:drug therapy*; D014859:Warfarin / Q000627:therapeutic use
D000925:Anticoagulants; D005343:Fibrinolytic Agents; D006629:Hirudins; D011994:Recombinant Proteins; D014859:Warfarin; D006493:Heparin; C083544:lepirudin